about
An Update on the Ophthalmologic Features in the PhakomatosesNeurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomographyMoyamoya Syndrome: A Window of Moyamoya DiseaseEliminating barriers to personalized medicine: learning from neurofibromatosis type 1Alternative splicing of the neurofibromatosis type I pre-mRNASmall G proteins in the cardiovascular system: physiological and pathological aspectsActivated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins[Dermatological diseases and their importance for psychiatry].Neurofibromatosis: chronological history and current issues.Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromesFatal retroperitoneal bleeding caused by neurofibromatosis: a case report and review of the literaturePulmonary arterial hypertension associated with neurofibromatosis type 1.Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma.TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.Neoplasms associated with germline and somatic NF1 gene mutationsRas in cancer and developmental diseasesSolid tumors associated with multiple endocrine neoplasias.Neurofibromatosis type 1: a single center's experience in Korea.Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibromaThe role of CELF proteins in neurological disorders.Spinal cord ependymoma associated with neurofibromatosis 1 : case report and review of the literature.Unusual case of angle closure glaucoma in a patient with neurofibromatosis type 1.Ras, ROS and proteotoxic stress: a delicate balance.Recurrent abdominal complaints caused by a cecal neurofibroma: a case report.A case of persistent foot pain in a neurofibromatosis type I patient.Type 1 neurofibromatosis and pheochromocytoma: Focus on hypertensionTargeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.Diffuse large B cell lymphoma presenting as Horner's syndrome in a patient diagnosed with neurofibromatosis type 1: a case report and review of the literature.Oncologic manifestations of neurofibromatosis type 1 in Korea.Recurrent retroperitoneal liposarcoma in a patient with neurofibromatosis type I.Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.Perioperative management of neurofibromatosis type 1.Posterior Spinal Reconstruction with Pedicle Screws, Multiple Iliac Screws and Wisconsin Spinal Wires in a Patient with Neurofibromatosis Scoliosis: A Case Report.Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.Synchronous neuroendocrine tumor and non-small-cell lung cancer in neurofibromatosis type 1126 novel mutations in Italian patients with neurofibromatosis type 1.Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells
P2860
Q26738915-771FAE5D-7A48-48A9-8913-7180B162BB0EQ26743449-7832ED6C-DDF9-4ABF-B430-B7976294DE64Q26800801-186A0EFC-F5E2-4610-B5CE-565252841747Q26828988-99E8A482-3996-428F-AF07-46910527B707Q26865241-A8439C80-C623-4F1A-B1C6-C997D2F980CEQ27010607-0BFAC5E5-7050-43E3-A824-16F1D749C2D6Q27027458-97D3B991-3682-4102-814A-9854135F77EEQ30251786-817ACFCF-27DD-484C-9A6A-962BD9993D13Q30449267-D547CDED-A4F7-4C5B-9C36-2CD4718172DAQ30454537-547DFAEB-6751-4F9D-ADD4-76AE7FDFF972Q30894133-C3597F53-1BC5-4EC1-BD55-57CFD466181EQ33161531-473BAC4A-8E47-49F9-B662-6A4FE485CDF6Q33878831-8ED796A6-3FC0-42BF-8874-8F93D8602841Q34105259-4282F6FE-8E6D-4F4C-9E03-F61A437F6388Q34125947-29840837-5533-45D1-9CA8-8554E268E940Q34202697-78BCD144-18CA-4734-965B-F7D405F5DBB6Q34213017-EF4D9B87-B897-4486-8379-119C5C036279Q34347843-691ACD1A-227A-45FD-A9AD-4D6B6F68ECB3Q34350807-32F693B0-FCBF-4A2F-B2EF-00EDFA663CFFQ34625410-9CE3728D-9852-48D0-9488-C0F54E170044Q34706897-82C17604-7A2E-45E0-86D2-AF81A2845121Q35103115-2F0438DF-1FBC-4DB2-B5A3-352978ABBF05Q35127982-4ACB3BEE-18BD-4839-AED0-D36D1521A96BQ35230130-AD13D274-57B6-4431-ABE3-B79E59CF1C76Q35404338-6322EEFB-EFFC-4938-822E-1D738305D5C2Q35726032-A7AF38CA-9FF5-46B6-A0B0-2E23F33E209CQ35732986-9D4B931E-1D7B-4BAD-861C-D75DEF3886FDQ35804635-A73067E4-D015-4377-A259-5876D6942D07Q35858350-321F557B-1DBC-44B4-8B6E-E950BFC4D127Q35871503-392816CD-59D5-4010-818C-4E13F10A8A1EQ35976727-71BF2C9D-8CE6-46C1-8D89-619C7AA67D4EQ35987649-7585B3D6-68A7-43B6-85C9-46F2DEE3C197Q36008044-3C6691EC-F5D4-4E93-BB08-C7B484F3FFFBQ36071038-00F539D9-B91B-46DF-9F68-DF392DF1A5E7Q36215226-459547AA-A056-4CB3-A4CD-A39F1470BE4AQ36395077-2238FA84-F1E6-4DEF-A55F-AFEE68792468Q36410524-FFF63E6B-4D89-4039-8B0F-A0F5AA004797Q36411302-FCA38FF4-DC75-4AB7-8FD3-C90D0F66A49BQ36483309-F841BC73-A831-400C-AB20-B55169575611Q36517090-7B16E7BF-08E6-4313-802C-A347880A6600
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical and genetic aspects of neurofibromatosis 1.
@ast
Clinical and genetic aspects of neurofibromatosis 1.
@en
Clinical and genetic aspects of neurofibromatosis 1.
@nl
type
label
Clinical and genetic aspects of neurofibromatosis 1.
@ast
Clinical and genetic aspects of neurofibromatosis 1.
@en
Clinical and genetic aspects of neurofibromatosis 1.
@nl
prefLabel
Clinical and genetic aspects of neurofibromatosis 1.
@ast
Clinical and genetic aspects of neurofibromatosis 1.
@en
Clinical and genetic aspects of neurofibromatosis 1.
@nl
P1433
P1476
Clinical and genetic aspects of neurofibromatosis 1.
@en
P2093
Kimberly Jett
P2888
P356
10.1097/GIM.0B013E3181BF15E3
P407
P577
2010-01-01T00:00:00Z
P6179
1045207428